BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Neocentromeres
,
Clofibrate
,
rs2230926
,
PPARA
,
cell-cell adhesion
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LDL receptor
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Umbilical artery endothelial cells in response to estradiol and oxidized low density lipoprotein
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The LDL receptor is regulated by membrane cholesterol as revealed by fluorescence fluctuation analys…
Linkage Disequilibrium between LDLR rs688 and AvaII Genes and its Significant Association with Ische…
Modifying pH-sensitive PCSK9/LDLR interactions as a strategy to enhance hepatic cell uptake of low-d…
LDLR, LRP1, and Megalin redundantly participate in the uptake of Clostridium novyi alpha-toxin.
LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
LDL Receptor Under Ezetimibe and Simvastatin
Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities
Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)
Effect of Diet Induced Ketosis on LDL Turnover Rates
Impact of LDL-cholesterol Lowering on Platelet Activation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ